Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:35:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:22:29.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:40:54.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the prior v3.4.1 notice and the government-funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:52:34.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows a government funding lapse notice and a site revision tag (v3.4.1, replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:18.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Minor UI/text updates: a new 'Show glossary' option, capitalization tweaks in QC-related labels ('Last Update Submitted that Met QC Criteria'), the wording 'No FEAR Act Data' changed to 'No FEAR Act data', and a new 'Revision: v3.4.0' tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:34:32.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.